Pipeline diagram for Small Molecule Development Funding Opportunities.
Diagram has 4 stages: Discovery, Development, Phase 1, and Phase 2 and 3.
Reading from top to bottom:
The first 3 opportunities are NIH Standard R01, NIH Exploratory R21, and the NIDCD Translational R01. They include the Discovery stage only.
SBIR/STRR and NIDCD P50 include Discovery and the beginning of Development.
Numerous Trans-NIH PAs/PARs are available in all 4 stages.
Commercial Development includes Phase 1 and Phases 2 and 3.
NINDS Blueprint Neurotherapeutics includes Development and Phase 1.
NCATS Drug Development Collaboratory includes the end of Development, Phase 1, and Phases 2 and 3.
NCATS BrIDGs includes Discovery, Development, and Phase 1.
NCI NExT and the NINDS Blueprint Neurotherapeutics training course include all 4 stages.